Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2191095Generated: November 1, 2026

Methyl iodide → HCID 68774665, compound

https://huagongshe.com/reaction/2191095

Reaction equation

Participants

RoleNameHCIDCharge
ReactantMethyl iodideHCID 6328—
ReactantSodium hydrideHCID 24758—
Reactant3-Aminoazetidine, 3-BOC protectedHCID 1519405—
ReactantPotassium tert-butoxideHCID 23665647—
ReactantHCID 87571193HCID 87571193—
Catalyst2-(2'-Di-tert-butylphosphine)biphenylpalladium(II) acetateHCID 11982262—
SolventDimethylformamideHCID 6228—
Solvent1,4-DioxaneHCID 31275—
ProductHCID 68774665HCID 6877466531%

Reaction Steps

A mixture of Example 360 (200 mg, 0.35 mmol), azetidin-3-ylcarbamic acid tert-butyl ester (125 mg, 0.71 mmol), potassium tert-butoxide (60 mg, 0.49 mmol) and acetato(2′-di-tert-butylphosphino-1,1′-biphenyl-2-yl)palladium(II) (10 mg, 0.02 mmol) in 1,4-dioxane (3.0 mL) was heated in a sealed tube at 100° C., under microwave irradiation, for 30 minutes. The solvent was removed in vacuo and the residue was purified by column chromatography (SiO2, 0-100% EtOAc/heptane). To a solution of the obtained solid in DMF (10 mL) was added sodium hydride (60% dispersion in oil, 10 mg, 0.24 mmol) and the reaction was stirred at room temperature for 30 minutes. Methyl iodide (18 μL, 0.29 mmol) was added and stirring was continued at room temperature for 18 h. Further sodium hydride (60% dispersion in oil, 10 mg, 0.24 mmol) was added and stirring was continued for 2 h at room temperature. The solvent was removed in vacuo and the residue was purified by column chromatography (SiO2, 0-100% EtOAc/heptane). To a solution of the obtained solid in DCM (8 mL) was added TFA (2 mL) and the reaction mixture was stirred at room temperature for 2 h. The solvent was removed in vacuo and the residue was partitioned between DCM (20 mL) and saturated aqueous sodium hydrogencarbonate solution (20 mL). The organic phase was concentrated in vacuo and was purified by column chromatography (SiO2, 0-20% MeOH/DCM) to give the title compound (5 mg, 31%) as a clear glass. δH(CD3OD) 8.68 (1H, d, J 5.1 Hz), 7.91 (1H, s), 7.44 (1H, dd, J 5.3, 1.7 Hz), 7.39-7.29 (2H, m), 7.14-7.08 (1H, m), 6.68-6.60 (1H, m), 4.29-4.17 (2H, m), 4.02-3.91 (1H, m), 3.74-3.56 (6H, m), 3.15-3.01 (4H, m), 2.64 (2H, s), 2.47 (2H, m), 1.05 (6H, s). LCMS (ES+) 503.3 (M+H)+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08324204B2
Source datasetuspto-grants-2012_12
ORD IDord-4fb1801fa7804bceb9cdd4e35588b010
Source noteuspto-grants-2012_12